Showing results (1781-1790 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|January 1, 1985
First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancerP Periti, G R della Cuna, F Pannuti, et al.
Investigational New Drugs|January 1, 1985
Phase II studies of mitoxantrone in patients with primary liver cancerG Falkson, B J Coetzer
Investigational New Drugs|January 1, 1985
Mitoxantrone in malignant lymphomaR A Gams, S Bryan, G Dukart, et al.
Investigational New Drugs|August 21, 2025
Tackling tumor hypoxia: advances in breaking the oncogenic HIF-1α-p300/CBP allianceEmadeldin M Kamel, Sally Mostafa Khadrawy, Ahmed A Allam, et al.
Investigational New Drugs|February 15, 2023
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a studyMarkus Joerger, Thomas Hundsberger, Simon Haefliger, et al.
Investigational New Drugs|March 13, 2023
A phase 1b study of the allosteric extracellular FGFR2 inhibitor alofanib in patients with pretreated advanced gastric cancerIlya Tsimafeyeu, Galina Statsenko, Liubov Vladimirova, et al.
Investigational New Drugs|March 13, 2023
Anticancer effect of zanubrutinib in HER2-positive breast cancer cell linesHana Dostálová, Radek Jorda, Eva Řezníčková, et al.
Investigational New Drugs|March 9, 2023
Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 studyJames Chih-Hsin Yang, Wu-Chou Su, Chao-Hua Chiu, et al.
Investigational New Drugs|August 26, 2021
Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case reportFrancesco Gelsomino, Alessandro Di Federico, Maria Lucia Tardio, et al.
Investigational New Drugs|August 10, 2022
Phase I study of lurbinectedin in combination with weekly paclitaxel with or without bevacizumab in patients with advanced solid tumorsEmiliano Calvo, Cristiana Sessa, Guilherme Harada, et al.
Pageof 372